Myers Jennifer S, von Lersner Ariana K, Sang Qing-Xiang Amy
1. Department of Chemistry & Biochemistry, Florida State University, Tallahassee, FL, USA.
1. Department of Chemistry & Biochemistry, Florida State University, Tallahassee, FL, USA.; 2. Institute of Molecular Biophysics, Florida State University, Tallahassee, FL, USA.
J Cancer. 2016 Jul 5;7(11):1452-64. doi: 10.7150/jca.15860. eCollection 2016.
Protein profiling studies of prostate cancer have been widely used to characterize molecular differences between diseased and non-diseased tissues. When combined with pathway analysis, profiling approaches are able to identify molecular mechanisms of prostate cancer, group patients by cancer subtype, and predict prognosis. This strategy can also be implemented to study prostate cancer in very specific populations, such as African Americans who have higher rates of prostate cancer incidence and mortality than other racial groups in the United States. In this study, age-, stage-, and Gleason score-matched prostate tumor specimen from African American and Caucasian American men, along with non-malignant adjacent prostate tissue from these same patients, were compared. Protein expression changes and altered pathway associations were identified in prostate cancer generally and in African American prostate cancer specifically. In comparing tumor to non-malignant samples, 45 proteins were significantly cancer-associated and 3 proteins were significantly downregulated in tumor samples. Notably, fatty acid synthase (FASN) and epidermal fatty acid-binding protein (FABP5) were upregulated in human prostate cancer tissues, consistent with their known functions in prostate cancer progression. Aldehyde dehydrogenase family 1 member A3 (ALDH1A3) was also upregulated in tumor samples. The Metastasis Associated Protein 3 (MTA3) pathway was significantly enriched in tumor samples compared to non-malignant samples. While the current experiment was unable to detect statistically significant differences in protein expression between African American and Caucasian American samples, differences in overrepresentation and pathway enrichment were found. Structural components (Cytoskeletal Proteins and Extracellular Matrix Protein protein classes, and Biological Adhesion Gene Ontology (GO) annotation) were overrepresented in African American but not Caucasian American tumors. Additionally, 5 pathways were enriched in African American prostate tumors: the Small Cell Lung Cancer, Platelet-Amyloid Precursor Protein, Agrin, Neuroactive Ligand-Receptor Interaction, and Intrinsic pathways. The protein components of these pathways were either basement membrane proteins or coagulation proteins.
前列腺癌的蛋白质谱研究已被广泛用于表征病变组织与非病变组织之间的分子差异。与通路分析相结合时,谱分析方法能够识别前列腺癌的分子机制,按癌症亚型对患者进行分组,并预测预后。该策略也可用于研究非常特定人群中的前列腺癌,比如非裔美国人,他们的前列腺癌发病率和死亡率高于美国其他种族群体。在本研究中,对年龄、分期和Gleason评分相匹配的非裔美国男性和欧裔美国男性的前列腺肿瘤标本,以及这些患者相同的非恶性前列腺组织进行了比较。在前列腺癌总体以及非裔美国人前列腺癌中分别确定了蛋白质表达变化和改变的通路关联。在将肿瘤样本与非恶性样本进行比较时,有45种蛋白质与癌症显著相关,且有3种蛋白质在肿瘤样本中显著下调。值得注意的是,脂肪酸合酶(FASN)和表皮脂肪酸结合蛋白(FABP5)在人类前列腺癌组织中上调,这与其在前列腺癌进展中的已知功能一致。醛脱氢酶家族1成员A3(ALDH1A3)在肿瘤样本中也上调。与非恶性样本相比,转移相关蛋白3(MTA3)通路在肿瘤样本中显著富集。虽然当前实验未能检测到非裔美国人和欧裔美国人样本之间蛋白质表达的统计学显著差异,但发现了在代表性过高和通路富集方面的差异。结构成分(细胞骨架蛋白和细胞外基质蛋白类别,以及生物粘附基因本体(GO)注释)在非裔美国人肿瘤中代表性过高,但在欧裔美国人肿瘤中并非如此。此外,有5条通路在非裔美国人前列腺肿瘤中富集:小细胞肺癌、血小板-淀粉样前体蛋白、聚集蛋白、神经活性配体-受体相互作用和内在通路。这些通路的蛋白质成分要么是基底膜蛋白,要么是凝血蛋白。